These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 29559746

  • 1. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Chu PC, Lin PC, Wu HY, Lin KT, Wu C, Bekaii-Saab T, Lin YJ, Lee CT, Lee JC, Chen CS.
    Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
    [Abstract] [Full Text] [Related]

  • 2. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC, Tsai TY, Yadav VK, Deng L, Huang CC, Tzeng YM, Yeh CT, Chen MY.
    Int J Mol Sci; 2021 Jul 14; 22(14):. PubMed ID: 34299137
    [Abstract] [Full Text] [Related]

  • 3. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC, Qian Y, Li X, Xu J, Kang W, Tong JH, To KF, Jin Y, Li W, Chen H, Go MY, Wu JL, Cheng KW, Ng SS, Sung JJ, Cai Z, Yu J.
    Gastroenterology; 2016 Nov 14; 151(5):945-960.e6. PubMed ID: 27451147
    [Abstract] [Full Text] [Related]

  • 4. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S, Liu H, Hou S, Wu L, Yang Z, Shen J, Zhou L, Zheng SS, Jiang B.
    Clin Transl Oncol; 2018 Jun 14; 20(6):703-712. PubMed ID: 29071516
    [Abstract] [Full Text] [Related]

  • 5. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, Wang FH, Chiao LJ, Pelicano H, Huang P, Li YH, Xu RH.
    Hepatology; 2014 Aug 14; 60(2):598-609. PubMed ID: 24616020
    [Abstract] [Full Text] [Related]

  • 6. Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
    Eder S, Arndt A, Lamkowski A, Daskalaki W, Rump A, Priller M, Genze F, Wardelmann E, Port M, Steinestel K.
    Cancer Lett; 2017 Jan 28; 385():160-167. PubMed ID: 27793696
    [Abstract] [Full Text] [Related]

  • 7. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
    Vitiello PP, Cardone C, Martini G, Ciardiello D, Belli V, Matrone N, Barra G, Napolitano S, Della Corte C, Turano M, Furia M, Troiani T, Morgillo F, De Vita F, Ciardiello F, Martinelli E.
    J Exp Clin Cancer Res; 2019 Jan 28; 38(1):41. PubMed ID: 30691487
    [Abstract] [Full Text] [Related]

  • 8. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
    Li Z, Liu J, Chen H, Zhang Y, Shi H, Huang L, Tao J, Shen R, Wang T.
    Carcinogenesis; 2020 Jun 17; 41(4):467-477. PubMed ID: 31675755
    [Abstract] [Full Text] [Related]

  • 9. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
    Wang D, Wang X, Si M, Yang J, Sun S, Wu H, Cui S, Qu X, Yu X.
    Cancer Lett; 2020 Apr 01; 474():36-52. PubMed ID: 31931030
    [Abstract] [Full Text] [Related]

  • 10. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S, Qiu J, Liu L, Su C, Qi L, Huang C, Chen X, Zhang Y, Ye Y, Ding Y, Liang L, Liao W.
    J Exp Clin Cancer Res; 2020 Aug 25; 39(1):168. PubMed ID: 32843066
    [Abstract] [Full Text] [Related]

  • 11. DNMT1 maintains the methylation of miR-152-3p to regulate TMSB10 expression, thereby affecting the biological characteristics of colorectal cancer cells.
    Wang C, Ma X, Zhang J, Jia X, Huang M.
    IUBMB Life; 2020 Nov 25; 72(11):2432-2443. PubMed ID: 32918845
    [Abstract] [Full Text] [Related]

  • 12. Quadruple-editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS-mutated colorectal cancer cells.
    Wang Z, Kang B, Gao Q, Huang L, Di J, Fan Y, Yu J, Jiang B, Gao F, Wang D, Sun H, Gu Y, Li J, Su X.
    Cancer Sci; 2021 Sep 25; 112(9):3895-3910. PubMed ID: 34185934
    [Abstract] [Full Text] [Related]

  • 13. Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
    Hata T, Mokutani Y, Takahashi H, Inoue A, Munakata K, Nagata K, Haraguchi N, Nishimura J, Hata T, Matsuda C, Murata K, Mizushima T, Doki Y, Mori M, Yamamoto H.
    Int J Oncol; 2017 Feb 25; 50(2):487-496. PubMed ID: 28000854
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A, Pira G, Scanu AM, Uva P, Sotgiu G, Saderi L, Manca A, Serra C, Uleri E, Piu C, Caocci M, Ibba G, Zinellu A, Cesaraccio MR, Sanges F, Muroni MR, Dolei A, Cossu-Rocca P, De Miglio MR.
    Int J Med Sci; 2019 Feb 25; 16(11):1480-1491. PubMed ID: 31673240
    [Abstract] [Full Text] [Related]

  • 15. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
    Li X, Wang J, Zhang C, Lin C, Zhang J, Zhang W, Zhang W, Lu Y, Zheng L, Li X.
    J Pathol; 2018 Oct 25; 246(2):166-179. PubMed ID: 29943828
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C, Lin Y, Mao Y, Huang Z, Liu AY, Ma H, Yu D, Maitikabili A, Xiao H, Zhang C, Liu F, Luo Q, Ouyang G.
    Oncotarget; 2016 Apr 19; 7(16):21825-39. PubMed ID: 26968810
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Zhang D, Zhao L, Shen Q, Lv Q, Jin M, Ma H, Nie X, Zheng X, Huang S, Zhou P, Wu G, Zhang T.
    Int J Cancer; 2017 May 15; 140(10):2298-2309. PubMed ID: 28213952
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
    Amankwatia EB, Chakravarty P, Carey FA, Weidlich S, Steele RJ, Munro AJ, Wolf CR, Smith G.
    Br J Cancer; 2015 Apr 28; 112(9):1480-90. PubMed ID: 25919696
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Chen M, Lin M, Wang X.
    Oncol Rep; 2018 Feb 28; 39(2):619-626. PubMed ID: 29207158
    [Abstract] [Full Text] [Related]

  • 20. Dual inhibition of VEGF and PARP suppresses KRAS-mutant colorectal cancer.
    Zhong L, Wang R, Wang Y, Peng S, Ma Y, Ding S, Yang H, Chen S, Luo X, Wang W.
    Neoplasia; 2020 Sep 28; 22(9):365-375. PubMed ID: 32629177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.